vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与ULTRALIFE CORP（ULBI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是ULTRALIFE CORP的1.6倍（$75.5M vs $48.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 10.6%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $607.0K），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 7.5%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
超生命公司在全球范围设计、生产电池与通信系统，产品广泛服务于全球各国政府防务、医疗、安全保障、能源、机器人等领域的客户。公司脱胎于柯达旗下的Ultra Technologies电池部门，1991年通过首次公开募股成立，总部位于纽约州纽瓦克，主要业务涵盖电池等相关领域。
PBYI vs ULBI — 直观对比
营收规模更大
PBYI
是对方的1.6倍
$48.5M
营收增速更快
PBYI
高出17.2%
10.6%
自由现金流更多
PBYI
多$13.8M
$607.0K
两年增速更快
PBYI
近两年复合增速
7.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $48.5M |
| 净利润 | — | $-7.4M |
| 毛利率 | 69.3% | 24.9% |
| 营业利润率 | 22.7% | -21.9% |
| 净利率 | — | -15.3% |
| 营收同比 | 27.7% | 10.6% |
| 净利润同比 | — | -3925.8% |
| 每股收益（稀释后） | $0.26 | $-35.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIULBI
| Q4 25 | $75.5M | $48.5M | ||
| Q3 25 | $54.5M | $43.4M | ||
| Q2 25 | $52.4M | $48.6M | ||
| Q1 25 | $46.0M | $50.7M | ||
| Q4 24 | $59.1M | $43.9M | ||
| Q3 24 | $80.5M | $35.7M | ||
| Q2 24 | $47.1M | $43.0M | ||
| Q1 24 | $43.8M | $41.9M |
净利润PBYIULBI
| Q4 25 | — | $-7.4M | ||
| Q3 25 | $8.8M | $-1.2M | ||
| Q2 25 | $5.9M | $879.0K | ||
| Q1 25 | $3.0M | $1.9M | ||
| Q4 24 | — | $194.0K | ||
| Q3 24 | $20.3M | $258.0K | ||
| Q2 24 | $-4.5M | $3.0M | ||
| Q1 24 | $-4.8M | $2.9M |
毛利率PBYIULBI
| Q4 25 | 69.3% | 24.9% | ||
| Q3 25 | 77.7% | 22.2% | ||
| Q2 25 | 76.5% | 23.9% | ||
| Q1 25 | 77.1% | 25.1% | ||
| Q4 24 | 76.4% | 24.2% | ||
| Q3 24 | 63.9% | 24.3% | ||
| Q2 24 | 77.4% | 26.9% | ||
| Q1 24 | 75.5% | 27.4% |
营业利润率PBYIULBI
| Q4 25 | 22.7% | -21.9% | ||
| Q3 25 | 17.6% | -2.2% | ||
| Q2 25 | 12.7% | 4.6% | ||
| Q1 25 | 8.7% | 6.7% | ||
| Q4 24 | 22.6% | 3.4% | ||
| Q3 24 | 27.4% | 1.4% | ||
| Q2 24 | -4.6% | 9.1% | ||
| Q1 24 | -5.3% | 9.7% |
净利率PBYIULBI
| Q4 25 | — | -15.3% | ||
| Q3 25 | 16.2% | -2.8% | ||
| Q2 25 | 11.2% | 1.8% | ||
| Q1 25 | 6.5% | 3.7% | ||
| Q4 24 | — | 0.4% | ||
| Q3 24 | 25.2% | 0.7% | ||
| Q2 24 | -9.6% | 6.9% | ||
| Q1 24 | -11.0% | 6.9% |
每股收益（稀释后）PBYIULBI
| Q4 25 | $0.26 | $-35.00 | ||
| Q3 25 | $0.17 | $-0.07 | ||
| Q2 25 | $0.12 | $0.05 | ||
| Q1 25 | $0.06 | $0.02 | ||
| Q4 24 | $0.40 | $37.72 | ||
| Q3 24 | $0.41 | $0.02 | ||
| Q2 24 | $-0.09 | $0.18 | ||
| Q1 24 | $-0.10 | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $9.3M |
| 总债务越低越好 | $22.7M | — |
| 股东权益账面价值 | $130.3M | $130.0M |
| 总资产 | $216.3M | $216.9M |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资PBYIULBI
| Q4 25 | $97.5M | $9.3M | ||
| Q3 25 | $94.4M | — | ||
| Q2 25 | $96.0M | — | ||
| Q1 25 | $93.2M | — | ||
| Q4 24 | $101.0M | $6.9M | ||
| Q3 24 | $96.7M | $6.8M | ||
| Q2 24 | $96.8M | $6.7M | ||
| Q1 24 | $107.2M | $10.1M |
总债务PBYIULBI
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | $55.0M | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益PBYIULBI
| Q4 25 | $130.3M | $130.0M | ||
| Q3 25 | $115.3M | $137.3M | ||
| Q2 25 | $104.7M | $138.4M | ||
| Q1 25 | $97.1M | $136.4M | ||
| Q4 24 | $92.1M | $134.0M | ||
| Q3 24 | $71.1M | $134.5M | ||
| Q2 24 | $48.5M | $133.2M | ||
| Q1 24 | $51.0M | $128.8M |
总资产PBYIULBI
| Q4 25 | $216.3M | $216.9M | ||
| Q3 25 | $202.9M | $222.2M | ||
| Q2 25 | $194.9M | $221.0M | ||
| Q1 25 | $196.2M | $223.8M | ||
| Q4 24 | $213.3M | $220.5M | ||
| Q3 24 | $220.7M | $172.4M | ||
| Q2 24 | $205.0M | $169.8M | ||
| Q1 24 | $214.1M | $180.6M |
负债/权益比PBYIULBI
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | 0.41× | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $1.5M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $607.0K |
| 自由现金流率自由现金流/营收 | 19.1% | 1.3% |
| 资本支出强度资本支出/营收 | 0.0% | 1.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | $7.1M |
8季度趋势，按日历期对齐
经营现金流PBYIULBI
| Q4 25 | $14.4M | $1.5M | ||
| Q3 25 | $9.7M | $198.0K | ||
| Q2 25 | $14.1M | $5.9M | ||
| Q1 25 | $3.6M | $3.4M | ||
| Q4 24 | $15.6M | $3.0M | ||
| Q3 24 | $11.0M | $4.7M | ||
| Q2 24 | $1.0M | $8.9M | ||
| Q1 24 | $11.2M | $-81.0K |
自由现金流PBYIULBI
| Q4 25 | $14.4M | $607.0K | ||
| Q3 25 | $9.7M | $-797.0K | ||
| Q2 25 | $14.1M | $4.8M | ||
| Q1 25 | $3.6M | $2.5M | ||
| Q4 24 | $15.6M | $2.4M | ||
| Q3 24 | $11.0M | $4.2M | ||
| Q2 24 | $1.0M | $8.6M | ||
| Q1 24 | — | $-453.0K |
自由现金流率PBYIULBI
| Q4 25 | 19.1% | 1.3% | ||
| Q3 25 | 17.7% | -1.8% | ||
| Q2 25 | 26.8% | 10.0% | ||
| Q1 25 | 7.7% | 4.9% | ||
| Q4 24 | 26.4% | 5.6% | ||
| Q3 24 | 13.7% | 11.6% | ||
| Q2 24 | 2.1% | 19.9% | ||
| Q1 24 | — | -1.1% |
资本支出强度PBYIULBI
| Q4 25 | 0.0% | 1.8% | ||
| Q3 25 | 0.0% | 2.3% | ||
| Q2 25 | 0.0% | 2.3% | ||
| Q1 25 | 0.1% | 1.8% | ||
| Q4 24 | 0.0% | 1.4% | ||
| Q3 24 | 0.0% | 1.7% | ||
| Q2 24 | 0.0% | 0.8% | ||
| Q1 24 | 0.0% | 0.9% |
现金转化率PBYIULBI
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 2.41× | 6.75× | ||
| Q1 25 | 1.21× | 1.81× | ||
| Q4 24 | — | 15.70× | ||
| Q3 24 | 0.54× | 18.40× | ||
| Q2 24 | — | 3.01× | ||
| Q1 24 | — | -0.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
ULBI
| Commercial | $36.3M | 75% |
| Government Defense | $9.6M | 20% |
| Communications Systems Segment | $2.6M | 5% |
